Contrast media league table illustrates European domination
This article was originally published in Clinica
An examination of the leading contrast media players illustrates the extent to which European companies dominate the world market after last year's spate of US acquisitions. Once the 1994 deals are included, European manufacturers account for 84% of the world market which was worth about $3,300 million in 1993. Prior to the takeovers the Europeans' share was just below 60%.
You may also be interested in...
The fast-dissolving tablet will launch in early March. Its list price is not available but based on pricing for Allergan’s oral anti-CGRP Ubrelvy, ICER has said Biohaven’s rimegepant is likely to be cost-effective.
A surge in Chinese applications for clinical trials for coronavirus treatments, and a fall in patient numbers, are complicating recruitment efforts for the most promising drugs, prompting official moves to tighten study rules.